Quinolinic acid is a downstream product of the tryptophan→kynurenine pathway, classified as an endogenous neuroactive metabolite and an intermediate in NAD+ biosynthesis. 5-HIAA (5-hydroxyindoleacetic acid) is the primary urinary metabolite of serotonin, used for decades as a stable marker of serotonin catabolism. The ratio of these two metabolites is a biochemical index reflecting relative flux through kynurenine versus serotonin pathways. Historically, both markers have been measured in research and clinical chemistry to study tryptophan metabolism, neurotransmitter dynamics, and immune-related changes in metabolism. Biologically, quinolinic acid can influence excitatory (glutamate-related) signaling and is produced in pathways responsive to immune activation, while 5-HIAA reflects baseline serotonin turnover and clearance. Together the pair describes where tryptophan is being metabolized and the potential downstream effects on cellular signaling and redox balance.

Elevated Quinolinic Acid / 5-HIAA Ratio may indicate relatively greater flux through the kynurenine pathway compared with serotonin breakdown. This pattern is often associated with increased immune-driven enzyme activity, shifts in redox or oxidative stress, or altered neurotransmitter balance. Low ratio values suggest relatively higher serotonin turnover versus kynurenine-derived quinolinic acid, which can reflect different enzyme activity, substrate availability, or lower kynurenine pathway activation. Interpretation requires the full Cellular Zoomer context—compare with other kynurenine metabolites, tryptophan, inflammatory markers, neurotransmitter metabolites, and oxidative stress indicators before drawing conclusions.

This ratio is included in the Cellular Zoomer to map tryptophan pathway priorities—whether metabolic flow favors kynurenine-derived neuroactive compounds or serotonin turnover. It links neurotransmitter chemistry, immune-related pathway shifts, and oxidative context to mitochondrial and genetic findings, supporting a more personalized biochemical picture for clinical decision-making.